MicroRNA-21 Negatively Regulates Treg Cells Through a TGF-β1/Smad-Independent Pathway in Patients with Coronary Heart Disease

Abstract

Background: CD4+CD25+FoxP3+ regulatory T cells (Treg cells) play a protective role against the development and progression of the inflammatory disease atherosclerosis (AS). MicroRNA-21 (miR-21) is expressed in Treg cells and is up-regulated in the context of AS and other inflammatory diseases. Aims: This study aimed to determine the role of miR-21 in Treg cell regulation and gene expression during the development of AS in patients with coronary heart disease (CHD). Methods and Results: MiR-21 expression in peripheral blood mononuclear cells (PBMCs) was significantly up-regulated in patients with CHD (acute myocardial infarction (AMI) group, n=24; unstable angina (UA) group, n=21; stable angina (SA) group, n=24) compared with patients with chest pain syndrome (CPS, n=27), and miR-21 expression showed an increasing trend from SA to UA to AMI patients. Moreover, flow cytometry analysis indicated that the frequencies of circulating Treg cells decreased in a manner proportionate opposite with the level of miR-21. Quantitative real-time PCR (qRT-PCR) revealed a decrease in mRNA expression of forkhead box P3 (foxp3), transforming cell growth factor beta 1(TGF-β1) and smad7 (a known target gene of miR-21). ELISA analysis revealed a decrease in TGF-β1 secreted into the plasma. In addition, we transfected PBMCs with a miRNA negative control (NS-m), a miR-21 mimic (miR-21-m), a miRNA inhibitor negative control (NS-i), or a miR-21 inhibitor(miR-21-i). Up-regulation of miR-21 decreased the frequency of circulating Treg cells, decreased the expression levels of foxp3, TGF-β1 and smad7, and decreased the amount of TGF-β1 secreted into the plasma. Consistent with these observations, miR-21 down-regulation increased the frequency of circulating Treg cells, increased the expression of foxp3, TGF-β1 and smad7, and increased the amount of TGF-β1 secreted into the plasma. Conclusions: Because the smad7 expression pattern was similar to that of TGF-β, our study suggests that miR-21 can negatively regulate the frequency of circulating Treg cells through a TGF-β1/smad-independent signaling pathway in PBMCs.

MicroRNA-9 Inhibits NLRP3 Inflammasome Activation in Human Atherosclerosis Inflammation Cell Models through the JAK1/STAT Signaling Pathway

“…MicroRNAs have been reported to regulate cellular functions through signaling pathways[46, 47]. The JAK/STAT signal pathway plays key roles in a variety of important cellular responses, such as inflammation, cell growth, metabolism, and gene transcription [45].…”

The paradoxical role of tumor-infiltrating immune cells in lung cancer

“…Developmental pathways of Th17 and Treg cells are closely related. TGF-β alone induces expression of FoxP3 (30,31) and RORγT (31) in TCR-stimulated naive CD4 + T cells. Thus TGF-β is a critical factor for Th17 and Treg cells and is essential for inducing both RORγT and Foxp3.…”

“…Despite the induction of these transcription factors, TGF-β is unable to initiate Th17 differentiation in vitro unless pro-inflammatory cytokines, such as IL-6 or IL-21, are present. When these cytokines are present, the TGF-β-induced Foxp3 expression is down-regulated and RORγT expression is up-regulated (30,32). In the absence of significant inflammation, TGF-β promotes the differentiation of Treg cells, which maintain immune tolerance.…”

Strengthening Gastric Cancer Therapy by Trastuzumab-Conjugated Nanoparticles with Simultaneous Encapsulation of Anti-MiR-21 and 5-Fluorouridine

“…MiR-21 is a potential oncogenic miR involved in gastric cancer and is associated with trastuzumab and 5-Fu resistance [14, 15]. The miR overexpression is silenced by anti-miRs in a targeted manner [43]. AMO-21 was developed to specifically target miR-21.…”